Biotech Values

[TheFinalCD]

Thank you https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174382614

$CTMX hilarious price action. From press release, it was obvious partial responses were seen in pancreatic cancer and not yet in other cancers. Those partial responses are ongoing. Yet after a waterfall plot is shown market is newly skittish ?

— avidresearch (@avidresearch) May 8, 2024

Message in reply to:
CTMX—(-37%/AH)—My reading of the PR is that they had only 2 partial responses among 51 enrolled patients in all cancer types. The PR obfuscates, but it didn’t fool investors, evidently.

https://finance.yahoo.com/news/cytomx-therapeutics-announces-positive-initial-201000477.html